TNF Pharma - שווי פעילות לנפח מכירות TNFA

TNF Pharmaceuticals maintains its position through conjugate patents and biotech lobbying. The company's EV/Sales ratio reflects the business valuation trend, where expresses the current value of the metric. Small-molecule developments for the elderly create advantages, while specialized climate logistics guarantee supply security.
TNF Pharmaceuticals - פילוחים אנליטיים ומדדי מפתח (TNFA)

For the biotech business of TNF Pharmaceuticals (TNFA), whose revenue depends on the commercialization of immunomodulators and anti-aging drugs, the scale of operations determines investment attractiveness. This metric compares the total enterprise value with annual sales volume, excluding the impact of leverage, which allows the current EV/Sales value to assess the market premium per unit of revenue and determine the extent to which the asset is overvalued.